$Alphabet(GOOG)$ 2025Q3 crushed it! Revenue smashed the $100B mark for the first time, hitting $102.3B. With a solid ads foundation and AI monetization boosting margins, its stock performance ranked 2nd among the "Magnificent Seven". The "AI+Cloud" strategy is a powerful combo, making it a long-term bet. Bullish!
$Coinbase Global, Inc.(COIN)$ ’s edge lies in its unwavering compliance focus—a huge plus amid today’s tighter crypto regulations. Founder’s long-held belief in “doing things right” built a trusted brand. In finance, trust is everything.
$SharpLink Gaming(SBET)$ cashing in on esports hype! Small gains now but huge growth potential ahead. With gaming tournaments popping off, this stock's got game! Holding for next level gains!
$United States Oil Fund LP(USO)$ Reports that the U.S. might deepen its involvement in Israel’s military strikes on Iran sent energy traders rushing back into the market. Tensions flared even more after Trump made public threats and a high-level national security meeting was held. The rising geopolitical anxiety is clearly fueling a spike in oil market volatility.
$CTIHK(06055)$ Overall, CTIHK has a very solid business model, with a relatively stable guaranteed net profit every year and significant growth potential ahead. Although the stock price had already surged last year, the current P/E ratio of 18 still feels undervalued. If it were listed on the A-shares market, I believe it would start at least with a P/E ratio of 40. The potential is huge and definitely worth keeping an eye on!
$Intel(INTC)$ is on the right track! The company has officially confirmed smooth progress on its 18A process, with mass production expected by mid-year—marking a major breakthrough in advanced manufacturing. With a strong focus on integrating chip design and fabrication, and upcoming bold moves from the new CEO, Intel’s stock could be poised for a significant rally. The future looks promising!
$Novo-Nordisk A/S(NVO)$ has made remarkable strides by integrating AI into the drafting of regulatory drug documents. By utilizing Claude, they've reduced the time to draft clinical research reports from around 15 weeks to less than 10 minutes—an incredible leap in efficiency! What's even more impressive is that tasks that once required over 50 writers can now be completed by just 3 people with the help of Claude, all while spending less than the salary of one traditional writer. The introduction of AI has drastically lowered costs and enhanced accuracy, marking a major milestone in the future of the healthcare industry!